by Wiley Credit: Pixabay/CC0 Public DomainResearch published in the Journal of Internal Medicine indicates that SARS-CoV-2 infection may worsen lower urinary tract symptoms (LUTS) in men. The study included 17,986 men receiving medication for LUTS within the public health care system of Hong Kong in 2021–2022, half of whom had SARS-CoV-2 infection. The group with SARS-CoV-2...
Category: <span>Prognostic</span>
Urine Test Predicts Future Bladder Cancer 12 Years Before Symptoms
Neil Osterweil A simple urine test for genetic mutations in urine-derived DNA can predict urothelial cancer up to 12 years before patients develop symptoms, an international team of researchers claims. The test, if validated in further studies, has the potential to serve as a cancer screening tool for individuals at elevated risk for bladder cancer...
Mutation puts women at higher risk of heart failure
by Janosch Deeg, Max Delbrück Center for Molecular Medicine Cardiomyocytes with stained mitochondria (red), sarcomeres (green) and nuclei (blue). Credit: Klaassen Lab, Max Delbrück CenterWhen the PRDM16 gene mutates, heart muscle cells undergo changes in their metabolism. This increases the risk of congenital heart failure in women more than men, as a ECRC research team led...
Long COVID Leads to Greater Health Risks, Research Finds
Editor’s note: Find the latest long COVID news and guidance in Medscape’s Long COVID Resource Center. People who have been infected with the COVID-19 virus have a greater risk of many long-term health conditions, including diabetes, lung problems, fatigue, blood clots and disorders affecting the gastrointestinal and musculoskeletal systems. That is the finding of a...
Study Validates Use of New Psoriatic Arthritis Prediction Tool
Doug Brunk A new predictive tool known as the Psoriatic Arthritis Risk Estimation Tool (PRESTO) is now available to help clinicians estimate the risk of psoriatic arthritis (PsA) in their patients with psoriasis. Dr Lihi Eder Though it requires further validation, researchers led by rheumatologist Lihi Eder, MD, PhD, of the Women’s College Research Institute...
Protein score, from a single plasma sample, predicts atherosclerotic cardiovascular disease
DECODE GENETICS IMAGE: KARI STEFANSSON CEO OF DECODE GENETICS AND AUTHOR ON THE PAPER WITH HANNES HELGASON SCIENTIST AT DECODE GENETICS AND AUTHOR ON THE PAPER. view more CREDIT: DECODE GENETICS In a large retrospective analysis using measurements of thousands of plasma proteins in primary and secondary event populations, scientists from deCODE genetics a subsidiary...
Simple blood test may predict future heart, kidney risk for people with type 2 diabetes
by American Heart Association blood testCredit: Pixabay/CC0 Public DomainA simple blood test may predict the risk of progressive heart and kidney disease in people with type 2 diabetes and kidney disease, according to new research published in the journal Circulation. “High levels of certain biomarkers are indicators of heart and kidney complications and may help...
Study finds increased MDS/leukemia risks for survivors of common lymphoid neoplasms
by Elana Gotkine Survivors of common lymphoid neoplasms (LNs) have increased risks for therapy-related myelodysplastic syndrome/acute myeloid leukemia (tMDS/AML), although risks have been lower in more recent years, according to a study published in the July issue of e ClinicalMedicine. Lindsay M. Morton, Ph.D., from the National Cancer Institute in Bethesda, Maryland, and colleagues identified...
Reviewing MAFLD opens new treatment pathways
FIRST HOSPITAL OF JILIN UNIVERSITY Non-alcoholic fatty liver disease (NAFLD) is a common condition that affects up to 30% of adults in the general population. It is characterized by the accumulation of fat in the liver. It is often associated with other conditions, such as obesity, type 2 diabetes, and metabolic syndrome. The new definition...
First-of-its-kind study reveals predictive factors for outcomes of advanced stage AL amyloidosis
by American Society of Hematology Credit: Unsplash/CC0 Public Domain Early improvements in cardiac and hematologic parameters may predict better survival outcomes for patients being treated for stage IIIb AL amyloidosis, a deadly disease with a median survival of four to six months caused by abnormal protein buildup, according to research published in Blood Advances. Amyloidosis occurs when...